甲状腺外科疾病的生物治疗
Biotherapy in the treatment of surgical disorders of the thyroid
摘要
随着分子生物学技术的发展,疾病的生物学治疗是目前医学研究重点之一.有关甲状腺外科疾病的生物治疗取得了许多突破性结果.本文对近年来本领域生物治疗研究的一些热点进行介绍.
出处
《外科理论与实践》
2005年第6期497-499,共3页
Journal of Surgery Concepts & Practice
参考文献19
-
1Ando T,Latif R,Pritsker A,et al. A monoclonal thyroidstimulating antibody[J]. J Clin Invest,2002,110(11):1667-1674.
-
2Sanders J,Jeffreys J,Depraetere H,et al. Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function[J]. Thyroid,2004,14(8):560-570.
-
3Sanders J,Allen F,Jeffreys J,et al. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist[J]. Thyroid,2005,15(7):672-682.
-
4Cocks HC,Thompson S,Turner FE,et al. Role and regulation of the fibroblast growth factor axis in human thyroid follicular cells[J]. Am J Physiol Endocrinol Metab,2003,285(3):E460-469.
-
5Davies EL,Ramsden JD,Cocks H,et al. Adenovirusmediated expression of dominant negative fibroblast growth factor(FGF)receptor 1 in thyroid cells blocks FGF effects and reduces goitrogenesis in mice[J]. J Clin Endocrinol Metab,2003,88(9):4472-4480.
-
6Ramsden JD,Buchanan MA,Egginton S,et al. Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin,vascular endothelial growth factor,and fibroblast growth factor signaling[J].Endocrinology,2005,146(7):2895-2902.
-
7Nagayama Y,Nishihara E,Namba H,et al. Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre/loxP system[J]. Cancer Gene Ther,2001,8(1):36-44.
-
8Kim SB,Ahn IM,Park HJ,et al. Growth inhibition and chemosensitivity of poorly differentiated human thyroid cancer cell line(NPA)transfected with p53 gene[J]. Head Neck,2001,23(3):223-229.
-
9Barzon L,Gnatta E,Castagliuolo I,et al. Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma[J]. Cancer Gene Ther,2005,12(4):381-388.
-
10Imanishi R,Ohtsuru A,Iwamatsu M,et al. A histone deacetylase inhibitor enhances killing of undifferentiated thyroid carcinoma cells by p53 gene therapy[J]. J Clin Endocrinol Metab,2002,87(10):4821-4824.
二级参考文献8
-
1[1]O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth.Cell,1997,88(2):277
-
2[2]Gasparini G.The rationale and future potential of angiogenesis inhibitors in neoplasia.Drugs,1999,58(1):17
-
3[3]Lennard CM, Patel A, Wilson J, Reinhardt B, et al.Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.Surgery,2001,129(5):552
-
4[4]Huang SM, Lee JC, Wu TJ,et al.Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.World J Surg,2001,25(3):302
-
5[5]Akslen LA, Livolsi VA.Increased angiogenesis in papillary thyroid carcinoma but lack of prognostic importance. Hum Pathol,2000,31(4):439
-
6[6]Soh EY, Eigelberger MS, Kim KJ,et al.Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo.Surgery,2000,128(6):1059
-
7[7]Belletti B, Ferraro P, Arra C, et al.Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene. Oncogene,1999,18(34):4860
-
8[8]Feldman AL, Alexander HR, Hewitt SM, et al.Effect of retroviral endostatin gene transfer on subcutaneous and intraperitoneal growth of murine tumors. J Natl Cancer Inst,2001,93(13):1014
共引文献4
-
1崔澄,胡建军,杨彦忠.VEGF在肿瘤免疫抑制中的作用及其临床应用前景[J].白求恩军医学院学报,2005,3(1):44-47. 被引量:2
-
2杨彦忠,李进让,张燕.肿瘤免疫抑制因子与头颈部肿瘤[J].临床耳鼻咽喉科杂志,2005,19(12):573-576. 被引量:1
-
3马建仓,李宗禹,徐金锴,赖婧玥,关昊.长链非编码RNA LINC00271过表达抑制甲状腺癌细胞FTC-133恶性生物学行为及裸鼠移植瘤的生长[J].广西医科大学学报,2020,37(8):1462-1468. 被引量:3
-
4王深明.甲状腺癌的基因治疗[J].外科理论与实践,2003,8(4):286-288. 被引量:2
-
1郑泽霖,孙辉,盖宝东.甲状腺疾病外科治疗的热点和难点[J].中国普外基础与临床杂志,2008,15(5):307-310. 被引量:40
-
2王方玉,赵娟,张敏.浅谈甲状腺手术前后的护理[J].工企医刊,2003,16(4):73-74.
-
3罗爱林.心内直视手术与免疫[J].国外医学(麻醉学与复苏分册),1995,16(3):140-143. 被引量:3
-
4张成文.关于肾综合征出血热──肾综合征出血热治疗研究进展[J].中国公共卫生,1996,12(10):433-435. 被引量:1
-
5李祥民.原发性肾小球肾炎的免疫治疗进展[J].国外医学(泌尿系统分册),1989,9(5):220-223.
-
6张洪义.异种移植[J].空军总医院学报,1999,15(1):24-26.
-
7李永柏.肾小球疾病的免疫疗法[J].中国实用儿科杂志,1998,13(4):200-203. 被引量:5
-
8王立明,闵志廉,朱有华,齐隽.尸体肾移植术后早期急性肾小管坏死的诊断和处理[J].肾脏病与透析肾移植杂志,1998,7(1):48-49.
-
9Placik OJ,苏涛.瘢痕疙瘩的免疫学关系[J].国外医学(创伤与外科基本问题分册),1993,14(3):154-156. 被引量:1
-
10陈贤楠,耿荣.感染性休克的免疫治疗[J].中国实用儿科杂志,1998,13(4):206-207. 被引量:13